Extensive Pain Management Devices Market Forecasts Report from 2018-2028 by Region/Country and Subsectors

Feb 26, 2020: The global pain management devices Market is set to grow at an exponential CAGR by the year 2028 attributed to a growing emphasis on expanding the product portfolios. The demand for pain management device market is majorly driven by the continuously up scaling geriatric population. Fixed battery life, limitations in power output and its frequency levels are the major drawbacks of these devices, which is hampering the market growth.

The market has recognized a trifurcation into pumps, simulators, and ablation devices based on the product type. The simulator industry has been further segmented into transcutaneous electrical nerve stimulation (TENS) devices and neuromodulator devices. Cryoablation devices microwave devices and others have been identified as the primary segmentation of ablation devices. Pumps are categorized into analgesic infusion type and other. Analgesic infusion pumps sub-segmented into external infusion pumps and intrathecal infusion pumps.

Request a Free Sample Copy of Pain Management Devices Market Report @  https://www.radiantinsights.com/research/2013-2028-report-on-global-pain-management-devices-market/request-sample

Based on application or end-user, the pain management devices market has been segmented into cancer pain, migraine, musculoskeletal pain, and others. The pain management devices market, by mode of purchase, has been divided into an over-the-counter device and prescription-based device type.

The comprehensive overview of the pain management devices market has acknowledged North America, Latin America, the Middle East & Africa, Europe and the Asia Pacific as the key regions. The Asia Pacific region has been regarded as an attractive destination for key contenders who are imploring to expand the global market space. Japan and China have been attributed as the largest aged population concentrated countries in the world, which has made them the major pursuit of market expansion. India has been positioned to be the fasted growing country in terms of building healthcare infrastructure and R&D activities. DJO Global in the year 2013 announced their upcoming objective of launching more than 10 pain management device distribution location, attributed to the high growth opportunities in the country.

Some of the major contenders functioning in the pain management devices market include Medtronic, Inc., Boston Scientific Corporation, Baxter International, Inc., DJO Global LLC., St. Jude Medical, Inc., Kimberly-Clark Healthcare, Pain Management, Inc., and Stryker Corporation among others. Other prominent vendors comprise Baxter Healthcare Corp. , BioMedical Life Systems, Inc., B. Braun Melsungen AG, CME Medical, Bio-Medical Research (BMR) Ltd, GF Health Products, Inc., NeuroTherm, Inc., Smiths Medical, Stryker Corp., Codman And Shurtleff, Inc., Flowonix Medical, Inc., Hospira, Inc., Omron Healthcare Co. Ltd, Sorenson Medical Products, Inc., and Zynex Medical, Inc. The key players are keen on developing the most advanced pain management systems for catering bulking demand across the end-user segments. This has characterized an enormous competition among the market players involved in building an efficient healthcare infrastructure and is significantly contributing to the market growth.

The report “Pain Management Devices Market” is available now at  https://www.radiantinsights.com/research/2013-2028-report-on-global-pain-management-devices-market

Pain management device manufacturing companies, government bodies, key vendors, major distributors and suppliers, contract manufacturing organizations (CMOs) and contract research organizations (CROs), research institutions and universities, etc. have been identified as the primary stakeholders of the pain management devices market.

Quell is a wearable, electrical nerve trainer stimulating the peripheral nerves leading to instant pain relief. This device stipulates the activity of sensory nerves, thus, initiating a pain derogation carried by nociceptive afferents. Over the past 20 years, electrical stimulation has determined a dynamic range of effective clinical implication. The Quell technology has created a sophisticated and non-invasive simulation device for treating chronic pain.

SCS, neuromuscular stimulation, and peripheral nerve stimulation have been ascribed as the latest technologies developed for neurostimulation. It is a minimally invasive method of vagal nerve therapy that allows programming of specialized stimulation pulse patterns to substantially reduce neuropathic pain.

To read more reports of this category, Visit our blog:  https://medicaldevicesmarketreports.tumblr.com 

Tonometer Market Will Witness Substantial Growth in the Forecast Period

Feb 25, 2020: Global Tonometer market is anticipated to witness substantial growth in the forecast period due to increase in cases of eye disorders, such as dry eye, thyroid ophthalmopathy, (AMD) Age-Related Macular Degeneration, and cataracts, among others. Tonometers are used to measure internal pressure of the eye. This instrument specially detects the pressure in the eyes, which otherwise if ignored for long time causes glaucoma. Since few eye disorders do not reveal any symptoms, it is always recommended to have them checked after specific time periods.

Request a Free Sample Copy of Tonometer Market Report @  https://www.radiantinsights.com/research/global-tonometer-market-outlook-2018-2023/request-sample 

The major driving factors witnessed in the tonometer market include growing geriatric population, increase in incidences of glaucoma, increase in risk of glaucoma as an genetic disorder, rise in diabetic population, since they are more prone to eye disorders, innovations in tonometers, and multiple complexities in detecting eye disorders. However, increasing use of ‘Goldmann applanation tonometers’ resulting in the risk of spreading infection or corneal abrasion is hampering the market. Additionally, the lack of skilled physicians is another restraining factor in the domain.

Increase in incidences of ocular disorders is an opportunity for the manufacturers to introduce more efficient devices for meets the needs of end users, such as clinicians, eye specialists, and hospital physicians. Nevertheless, poor measurement accuracy of ocular pressure by this device and availability of substitutes for tonometers are few challenges in the industry.

Lately in World Glaucoma Week, 10th - 16th March, 2019, Specsavers Store, Burnham studied approximate 22800 patients suffering from glaucoma. Glaucoma often leads to blindness and is considered to be more prevalent in men than women. With respect to increasing cases of the severe disorder, the store is focusing on creating awareness among individuals for the importance of regular eye checkup and avoiding glaucoma like disorders. Store director of Specsavers, Scott McGowan, in Somerset said that the disorder occurs when naturally-occurring liquid in the eye is unable to drain properly, leading to the creation of pressure.

For further inquiries, about - Global Tonometer Industry Analysis, Size, Growth, Trends and Forecast 2018 - 2023, click on this link – https://www.radiantinsights.com/research/global-tonometer-market-outlook-2018-2023

The prominent tonometer market players in the industry comprise Icare Finland Oy, Canon Inc., Topcon Corporation, Accutome, HAAG-STREIT GROUP, Reichert Technologies NIDEK CO., LTD., Huvitz, Kowa, OCULUS Optikgerate, Keeler, Reichert, Topcon, Suoer, TOMEY, 66 Vision-Tech, and Tiolat.

The 'Global Tonometer Market Outlook 2018-2023' offers detailed coverage of tonometer industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading tonometer producers to provide exhaustive coverage of the market for tonometer. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.
The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global tonometer market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Disposable Syringe Market Size, Demand and Production Forecasts to 2023

Feb 24, 2020: The global disposable syringe market is expected to register a robust CAGR during the forecast period. Syringe is a medical instrument for injecting any fluid in form of medicine into the body of human beings or any other animal. Technically, it consists of an airtight piston and a round cylinder. The medicines that need intravenous route of administration for medicines that cannot be taken orally or mixing with food.

Glass was used in the early days for production of these syringes, which was commonly known as Pyrex glass. At present, disposable syringes are made of polypropylene and are available in various sizes. Since, plastic has gained a lot of prominence; it is a proven substitute for glass and helps in saving natural resources. Therefore, constant development in polymer technology, cost effective production and processing machinery has helped the disposable syringes market to grow by leap and bounds.

Request a Free Sample Copy of Disposable Syringe Market Report @  https://www.radiantinsights.com/research/global-disposable-syringe-market-outlook-2018-2023/request-sample

Disposable syringe market is driven by rise in demand for injectable drugs. Increase in R&D activities and development of self-injection devices with high efficiency is likely to enhance the market growth during the forecast period. Investment by industry players for biologics and surge in demand is more likely to propel the market growth during the forecast period. Biologics have a prominent position in the medical field owing to their features and advantages.

By type, the disposable syringe market is segmented as safety syringes and conventional syringes. Application category is bifurcated as therapeutic injections and immunization injections. By product categorization, the market comprises retractable and non-retractable products. Non-retractable products are likely to gain a higher position during the prediction period.

Geographical segmentation for disposable syringe market report are North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share during the forecast period due to higher prevalence of chronic disease and rise in preference for injectable drugs. Introduction of new drugs and technologies are more likely to propel the market growth.

For further inquiries, about - Global Disposable Syringe Industry Analysis, Size, Growth, Trends and Forecast 2018 - 2023, click on this link – https://www.radiantinsights.com/research/global-disposable-syringe-market-outlook-2018-2023

European market houses majority of the key players and hence there exists a robust regulatory framework for drugs and medicine. Moreover, European governments have necessitated the use of engineered devices in medical and healthcare facilities resulting in high standards for patient safety by healthcare personnel. The key players profiled in the disposable syringe market report are Flextronics International Vita and Braun Medical Inc.

Global Market for disposable syringe to 2023 offers detailed coverage of disposable syringe industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading disposable syringe producers to provide exhaustive coverage of the disposable syringe.

Report contents include
- Analysis of the disposable syringe market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on disposable syringe including products, sales/revenues, and market position
- Market structure, market drivers and restraints.

To read more reports of this category, Visit our blog:  https://healthandpharamceuticalri.blogspot.com

 Key regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key vendors
- request free sample to get a complete list of companies

Inflammatory Bowel Disease Treatment Market Will Have Positive Impact Due To Growing Geriatric Population

Feb 18, 2020: The global inflammatory bowel disease treatment market size is expected to reach USD 22.4 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.4% CAGR during the forecast period. Increasing prevalence and incidence of Crohn's disease and ulcerative colitis is one of the major factors contributing to the market.

According to a study published in the NCBI in 2019, the North America incidence of inflammatory bowel disease (IBD) treatment is around 2.2 to 19.2 cases per 100,000 persons per year. It was also published that around 238 per 100,000 populations in U.S. were suffering from ulcerative colitis. Furthermore, The Centres for Disease Control and Prevention (CDC) estimates that in U.S., every year nearly 1-1.3 million people suffer from inflammatory bowel disease.

Request a Free Sample Copy of Inflammatory Bowel Disease Treatment Market Report @  https://www.radiantinsights.com/research/inflammatory-bowel-disease-treatment-market/request-sample

In addition, involvement of regulatory bodies for funding and designation is expected to propel the growth of the market. For instance, the Crohn's and Colitis Foundation offers grants and fellowships for research on inflammatory bowel disease (includes Crohn's disease and ulcerative colitis).

Growing geriatric population is expected to positively impact the overall market. According to an article published in 2018 in the United States Census Bureau, it is estimated that by 2035, the population aged 65 years and above is expected to reach 78 million, whereas children under the age of 18 might be around 76.7million.

Moreover, companies such as Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; and AbbVie Inc. are majorly involved in product research and development and this is also considered as one of the major driving factors for the market.

For further inquiries, about - Global Inflammatory Bowel Disease Treatment Industry Analysis, Size, Growth, Trends and Forecast 2019 - 2026, click on this link – https://www.radiantinsights.com/research/inflammatory-bowel-disease-treatment-market

Further key findings from the report suggest:

• The global inflammatory bowel disease treatment market is anticipated to reach USD 22.4 billion by 2026, exhibiting a CAGR of 4.4% from 2018 to 2026

• Crohn's disease dominated the market by type in 2018 due to increasing incidence of the disease. On the other hand, ulcerative colitis was estimated to be the fastest growing segment owing to presence of strong pipeline products for its treatment

• By route of administration, injectables dominated the IBD treatment market in 2018 while oral was estimated to be the fastest growing segment over the forecast period

• Aminosalicylic acid (ASAs) was considered to be the largest oral segment in 2018 and JAK inhibitors to be the fastest growing segment

• In 2018, TNF-inhibitors dominated the injectables segment while anti-integrins are estimated to be the fastest growing segment

• Hospital pharmacy was the largest segment in 2018 with a market share of 36.6% and online pharmacy was anticipated to be the fastest owing to the comfort, flexibility and convenience provided

• North America held the dominant share in 2018 owing to presence of key companies in this region. Asia Pacific, on the other hand, was estimated to be the fastest growing region

• Some of the key companies operating in this inflammatory bowel disease treatment market are Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences.